Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
Quotient Sciences to Host Ribbon Cutting at New Drug Substance Facility
£6 million expansion aims to deliver integrated support for customers bridging from candidate selection to early clinical development and beyond.12.08.22
-
Breaking News | R&D
Emmes Introduces Dedicated Cell and Gene Therapy Center
Will focus on supporting the clinical trials of clients who are developing cell and gene therapies around the world and across multiple therapeutic areas.12.08.22
-
Collaborations & Alliances | Drug Development
Vertex, Entrada Establish EEV Therapeutics Alliance for Myotonic Dystrophy
Entrada to receive $224 million upfront and $26 million equity investment, as well as potential milestone payments and royalties.12.08.22
-
Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News
Crown Bioscience, ERS Genomics Ink Global CRISPR/Cas9 Licensing Agreement
Crown Bioscience will expand its gene editing capabilities and investigate the prospect of gene editing in 3D patient-derived tumor organoid models.12.08.22
-
Clinical Trials | Drug Development
Biorepository & Archiving Best Practices: Free Up Frontline Critical Resources
Streamlining sample management, ensuring proper storage practices across the full chain of custody, and harmonizing data collection, storage and inventory.Radha Krishnan and Mac Winslow, Avantor 12.08.22
-
Collaborations & Alliances | Drug Development | Drug Discovery | Laboratory Testing
GenScript, Allozymes Partner to Advance Enzyme Discovery and Development
GenScript will provide the mutant libraries construction and expression and Allozymes will provide ultra-high-throughput screening.12.07.22
-
Drug Development | Drug Discovery | Laboratory Testing
How to Optimize Your Antibody Drug Candidate
Precision Mutant Library service aims to create a more precise and diverse mutant library that contains all desired variants with unbiased distribution.Videos
-
Bioanalytical Services | Breaking News | Industry News
Alliance Pharma Opens Bioanalytical Lab in Brisbane
New 20,000-sq.-ft. bioanalytical lab provides much-needed small and large molecule bioanalytical services in the region.12.07.22
-
Breaking News | Drug Development | Trials & Filings
Emergent’s sNDA for NARCAN OTC Gets Priority Review
If approved, would be the first 4 mg naloxone nasal spray available OTC in the U.S. for opioid overdose.12.06.22
-
Breaking News | Drug Development | Industry News
AbbVie, HotSpot Therapeutics Enter Strategic Immunology Alliance
Will leverage HotSpot's Smart Allostery drug discovery platform for the development of the first small molecule IRF5 for the treatment of autoimmune diseases.12.06.22
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture
GSK, Sanofi, Takeda, Singapore Researchers Partner to Boost Biologics Innovation
Aims to use research and innovation to grow Singapore's manufacturing capabilities for biologics, including recombinant therapeutic proteins, and vaccines.12.06.22
-
Aseptic Processing | Biologics, Proteins, Vaccines | Capsules | Clinical Trial Materials | Clinical Trials | Fill/Finish | Injectables | Lyophilization | Parenterals | Validation | Vials
Jubilant HollisterStier CMO
Jubilant HollisterStier Contract Manufacturing & Services is an integrated contract manufacturer of sterile injectables, ophthalmics, otics and sterile and non-sterile topicals and liquids.Jack Wright, VP Sales and Marekting 12.05.22
-
Microbiology
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
AbCellera, Rallybio Enter Strategic Antibody Alliance for Rare Diseases
Multi-target collaboration will combine AbCellera’s antibody discovery engine with Rallybio’s clinical and commercial expertise in rare diseases.12.01.22
-
Breaking News | Industry News | Laboratory Testing
Charles River Launches Endosafe Nexus 200
Next-gen robotic endotoxin testing system aims to boost manufacturing productivity in the lab.12.01.22
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Ferring's First-in-Class Microbiota-Based Live Biotherapeutic Approved
REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (CDI).12.01.22
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
BioVaxys Successfully Completes Sterile Test-Run for Ovarian Cancer Vax
The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols .12.01.22
-
Breaking News | Drug Delivery | Industry News
Recipharm Invests in Single Dose Nasal Platform Capabilities
Services available for full method development, formulation and container closure system, GLP material manufacturing and supply, development stability testing.11.30.22
-
Breaking News | Drug Development | Industry News | Laboratory Testing
Frontage Central Labs Awarded CAP Accreditation
Accreditation confirms the accuracy of test results, meet, and exceed CLIA, FDA and OSHA standards, and manage evolving lab changes.11.30.22
-
Breaking News | Collaborations & Alliances | Drug Development
Quotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03
Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain.11.29.22
